ACG Wealth’s Exact Sciences EXAS Stock Holding History

ACG Wealth’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,000	Closed	-$236K	–	345
2019 Q2	$236K	Buy	+2,000	New	+$202K	0.03%	306

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

ACG Wealth's EXAS Position: Q3 2019 in Review

ACG Wealth sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 2,000 shares — an estimated $236K sold.

ACG Wealth first reported a position in EXAS in Q2 2019 and held it in 1 quarter. The position peaked at $236K in Q2 2019. 474 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

ACG Wealth reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
ACG Wealth sold 2,000 Exact Sciences shares in Q3 2019, an estimated $236K.
ACG Wealth first reported a position in Exact Sciences in Q2 2019 and held it in 1 quarter.
ACG Wealth's Exact Sciences position peaked at $236K in Q2 2019.
474 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on ACG Wealth's 13F filing for Q3 2019, filed 30 Oct 2019.